Skip to main content
. 2021 Mar 2;45(7):1456–1465. doi: 10.1002/jpen.2061

Table 4.

SAEs Occurring in ≥5.0% of Patients

N = 89
Parameter (preferred terms) n (%) Number of events
Any SAE 69 (77.5) 254
Pyrexia 25 (28.1) 36
Device‐related infectiona 24 (27.0) 36
Influenza 9 (10.1) 9
Device breakagea 8 (9.0) 9
Dehydration 7 (7.9) 12
Upper respiratory tract infection 6 (6.7) 6

SAE, serious adverse event.

aAll device‐related events were related to central venous catheters used to administer parenteral support, not to the teduglutide injection device.